See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Natural Disasters
Social Media
Baseball
Earthquake
Artificial Intelligence
Tennis
Donald Trump
Taxes
European Union
Soccer
Stock Markets
Published • loading... • Updated

Sickle cell patient declared disease free after groundbreaking therapy on Long Island

Summary by WNYW
A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him disease free.

4 Articles

All
Left
Center
1
Right
WNYWWNYW
Center

Sickle cell patient declared disease free after groundbreaking therapy on Long Island

A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him disease free.

·San Francisco, United States
Read Full Article
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News

Next Breakthrough in Sickle Cell Therapy?

TOPLINE: Scientists at Johns Hopkins Medicine, Baltimore, have identified a potential new gene target, FLT1, that could be edited to treat sickle cell disease, an inherited blood disorder marked by sickle-shaped red blood cells causing intense pain and shortened lifespans. The discovery has expanded the knowledge of genes associated with fetal hemoglobin production in sickle […] The post Next Breakthrough in Sickle Cell Therapy? first appeared o…

Read Full Article
MedscapeMedscape

FLT1 Gene: Next Breakthrough in Sickle Cell Therapy?

Researchers map critical gene locations for fetal hemoglobin production, showing promise for treating sickle cell disease. Medscape Medical News

·United States
Read Full Article
Stemwell Science NewsStemwell Science News

Terumo Blood and Cell Technologies Partners with South Korea’s KBIOHealth to Help Develop Nation’s Cell and Gene Therapy Workforce

Terumo Blood and Cell Technologies (Terumo BCT) signed a memorandum of understanding with Osong Medical Innovation Foundation toward joint development of workforce training for cell and gene therapy manufacturing. The partners will begin by creating programs to support the manufacture of MSC and chimeric antigen (CAR) T cell therapies. [Terumo BCT] Press Release

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WNYW broke the news in San Francisco, United States on Tuesday, March 25, 2025.
Sources are mostly out of (0)

Similar News Topics

Medical

Medical

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal